MAR 21, 2019 5:43 PM PDT

More Evidence That High-Potency Pot is Linked to Psychosis

WRITTEN BY: Amy Loriaux

The debate surrounding the link between marijuana and psychosis continues. The general consensus up to this point acknowledges a possible risk, but there still is no causal link between the two. However, a new study, from Dr. Marta Di Forti and colleagues out of Kings College London, has just been published in the journal The Lancet - Psychiatry may shine some much-needed light on the subject. 

Photo source: UnSplash.com

Dr. Di Forti and colleagues present the results of the largest cross-sectional study to date according to the authors.  Psychiatric patients were recruited from sites across 10 European countries and Brazil. The study used patients aged 18–64 years who presented to psychiatric services across the 11 sites with first-episode psychosis. They recruited controls from local populations.  

The research group found that daily cannabis use was associated with an increased chance of developing a psychotic disorder compared with controls who had never used. This study contained participants (901 patients with first-episode psychosis and 1237 controls) definitely makes a statement, to say the least. What makes this study different from others (other than size), is the fact that these researchers added the degree of potency into the mix.

The potency of marijuana has increased tremendously in just the past 50 years. The researchers found that the use of high-potency cannabis (THC ≥10%) modestly increased the odds of having a psychotic disorder compared with controls. Those who had started using high-potency cannabis by age 15 years showed a doubling of risk.

 

Photo source: Pixabay.com

The authors' main conclusions were that, among the measures of cannabis use tested, the strongest independent predictors of whether any given individual would have a psychotic disorder or not were daily use of cannabis and use of high-potency cannabis. In the 3 sites with the greatest consumption of high-potency cannabis, daily use of high-potency cannabis was associated with the greatest increase in the chances of having a psychotic disorder compared with controls: 4x greater in Paris, 5x greater in London, and more than 9x greater in Amsterdam.

But the implications of this study do not stop there. The novelty of this study was in its multicenter structure and the availability of incidence rates for psychotic disorder for all the sites. This allowed the team, for the first time, to show how the association between cannabis use and risk of psychosis varies geographically depending on prevailing patterns of use, and how the latter contributes to variation in incidence rates for psychotic disorder.

Some limitations of this study included the fact that marijuana use was not verified using any biological markers (e.g. urine, blood, hair samples). Also, their index of potency was limited. They categorized potency as low and high potency on the basis of the available estimates of the average percentage of THC from "official sources".

Sources: Schizophrenia Bulletin, The Lancet, PotGuide.com

About the Author
  • I currently work at a small CRO involved in clinical trial management.
You May Also Like
JUL 23, 2020
Cannabis Sciences
Lab Tests Show Levels of THC Can Rise in CBD Oil During Storage
JUL 23, 2020
Lab Tests Show Levels of THC Can Rise in CBD Oil During Storage
To be federally legal in all states CBD (cannabidiol) oil must contain less than 0.3 percent of the psychoactive ingredi ...
JUL 29, 2020
Cannabis Sciences
CBD Tablets Help People Quit Cannabis
JUL 29, 2020
CBD Tablets Help People Quit Cannabis
Cannabis use disorder is essentially cannabis addiction. Although research suggests that it affects 9% of peop ...
AUG 16, 2020
Cannabis Sciences
Cannabinoids May Interact with Prescribed Medications
AUG 16, 2020
Cannabinoids May Interact with Prescribed Medications
Despite the growing popularity of cannabis products, information is currently limited on how they may interact with othe ...
AUG 25, 2020
Cannabis Sciences
Synthetic Cannabinoid Drug to Enter Human Trials
AUG 25, 2020
Synthetic Cannabinoid Drug to Enter Human Trials
In recent months, interest has been growing in the potential for cannabinoids- the compounds found in cannabis- to treat ...
SEP 01, 2020
Plants & Animals
Warsaw Zoo Testing CBD to Manage Elephants' Stress
SEP 01, 2020
Warsaw Zoo Testing CBD to Manage Elephants' Stress
Humans use cannabidiol (CBD) for its array of health benefits, and household pets even benefit from CBD treatments in sp ...
NOV 23, 2020
Health & Medicine
Federal Report Shows Teen Marijuana Treatment Admissions Have Been Falling
NOV 23, 2020
Federal Report Shows Teen Marijuana Treatment Admissions Have Been Falling
Concerns that the legalization of recreational marijuana might cause an upswing in young people misusing the drug have b ...
Loading Comments...